Spark Therapeutics reports upbeat data By: MarketMinute.com Stock News October 05, 2015 at 14:17 PM EDT Spark Therapeutics Inc. (Nasdaq: ONCE) reported upbeat data from a Phase 3 trial of SPK-RPE65 sending the stock price soaring $9.23 to $53.16. Related Stocks: Spark Therap